TRIM32 and gastric cancer: The knockdown of TRIM32 in gastric cancer cells, including NCI-N87, MKN74, and MKN45, resulted in increased apoptosis and decreased proliferation and AKT phosphorylation, which can be further enhanced by AKT inhibitors.